Cargando…
Staphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings
Glycopeptide resistance in Staphylococcus aureus is a source of great concern because, especially in hospitals, this class of antibiotics, particularly vancomycin, is one of the main resources for combating infections caused by methicillin-resistant Staphylococcus aureus strains (MRSA). Reduced susc...
Autores principales: | SPAGNOLO, A.M., ORLANDO, P., PANATTO, D., AMICIZIA, D., PERDELLI, F., CRISTINA, M.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore SpA
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718313/ https://www.ncbi.nlm.nih.gov/pubmed/26137787 |
Ejemplares similares
-
Reduced Susceptibility to Vancomycin in Staphylococcus aureus
por: Mimica, Marcelo J.
Publicado: (2011) -
Improving environmental quality in an operating room:
clinical outcomes and economic implications
por: SARTINI, M., et al.
Publicado: (2013) -
Operating theatre quality and prevention
of surgical site infections
por: SPAGNOLO, A.M., et al.
Publicado: (2013) -
Population Genomics of Reduced Vancomycin Susceptibility in Staphylococcus aureus
por: Rishishwar, Lavanya, et al.
Publicado: (2016) -
Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea
por: Park, Jung Wan, et al.
Publicado: (2019)